Christy J. Oliger - 07 Jun 2024 Form 3 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
07 Jun 2024
Net transactions value
$0
Form type
3
Filing time
11 Jun 2024, 16:15:00 UTC
Previous filing
30 May 2024
Next filing
02 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VERA Class A Common Stock 2,987 07 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. The RSUs are fully vested as to service and shall settle on a date in 2025, as determined by the Issuer.